Gavin represents the investment interests of Scottish Enterprise as Non-Executive Director at Lamellar, and is Managing Director of Marlin Bioconsulting Limited. He is an experienced life sciences licensing and commercial development professional. His previous roles include Vice President of Business Development for Tibotec-Virco NV and Commercial Director of Phares Technology BV. At GSK, he was responsible for Global Licensing Infectious Diseases, and held senior marketing and commercial management posts with Novartis, Bayer and Janssen. He co-founded novel class antibiotic company MGB Biopharma in 2009 and is an independent Non-Executive Director at EnteroBiotix Limited and cofounder of start-up Agilinx Therapeutics Limited.
Gavin serves on the advisory board of the Scottish Lifesciences Association, and as an Enterprise partner at University of Strathclyde. He is a Certified Licensing Professional as accredited by the Licensing Executives Society (USA and Canada).